TWIST1 induces proteasomal degradation of β-catenin during the differentiation of ovarian cancer stem-like cells

Sci Rep. 2022 Sep 19;12(1):15650. doi: 10.1038/s41598-022-18662-2.

Abstract

Ovarian cancer (OC) is one of the leading gynecologic cancers worldwide. Cancer stem-like cells are correlated with relapse and resistance to chemotherapy. Twist1, which is involved in ovarian cancer stem-like cell differentiation, is positively correlated with CTNNB1 in different differentiation stages of ovarian cancer cells: primary epithelial ovarian cancer cells (primary EOC cells), mesenchymal spheroid-forming cells (MSFCs) and secondary epithelial ovarian cancer cells (sEOC cells). However, the expression of β-catenin is inversed compared to CTNNB1 in these 3 cell states. We further demonstrated that β-catenin is regulated by the protein degradation system in MSFCs and secondary EOC but not in primary EOC cells. The differentiation process from primary EOC cells to MSFCs and sEOC cells might be due to the downregulation of β-catenin protein levels. Finally, we found that TWIST1 can enhance β-catenin degradation by upregulating Axin2.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Ovarian Epithelial
  • Cell Differentiation
  • Female
  • Humans
  • Krukenberg Tumor*
  • Neoplasm Recurrence, Local
  • Neoplastic Stem Cells
  • Nuclear Proteins / genetics
  • Ovarian Neoplasms* / metabolism
  • Twist-Related Protein 1 / genetics
  • beta Catenin / genetics
  • beta Catenin / metabolism

Substances

  • Nuclear Proteins
  • TWIST1 protein, human
  • Twist-Related Protein 1
  • beta Catenin